| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Feb 18, 2025 | C4 Therapeutics, Inc. | Chief Business Officer | Sell | 91.3 | +51,238 | 90.58% | ✓ | $16.7K |
| Nov 7, 2024 | Nov 12, 2024 | C4 Therapeutics, Inc. | Chief Business Officer | Sell | 47.5 | -1,102 | -1.91% | ✗ | $6.7K |
| Sep 16, 2024 | Sep 17, 2024 | C4 Therapeutics, Inc. | Chief Business Officer | Sell | 47.5 | -661 | -1.21% | ✗ | $4.2K |
| Feb 13, 2024 | Feb 15, 2024 | C4 Therapeutics, Inc. | Chief Business Officer | Sell | 91.3 | +25,565 | 95.52% | ✗ | $11.3K |
| Aug 30, 2023 | Aug 31, 2023 | C4 Therapeutics, Inc. | Chief Business Officer | Sell | 47.5 | -661 | -2.41% | ✗ | $1.9K |
| Jan 30, 2023 | Feb 1, 2023 | C4 Therapeutics, Inc. | Chief Business Officer | Sell | 47.5 | -1,222 | -19.10% | ✗ | $9.5K |
| May 26, 2022 | Jun 14, 2022 | C4 Therapeutics, Inc. | Chief Business Officer | Sell | 47.5 | -1,102 | -29.39% | ✗ | $7.7K |